These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25416055)

  • 1. Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary.
    Suh DS; Moon SH; Kim SC; Joo JK; Park WY; Kim KH
    World J Surg Oncol; 2014 Nov; 12():353. PubMed ID: 25416055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical significance of tumor markers in ovarian mature cystic teratoma.
    Chen JM; Gao HY; Wang Q; Li Q
    Clin Exp Obstet Gynecol; 2016; 43(3):397-400. PubMed ID: 27328499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
    Kataoka T; Watanabe Y; Hoshiai H
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated CA 19-9 levels in mature cystic teratoma of the ovary.
    Kyung MS; Choi JS; Hong SH; Kim HS
    Int J Biol Markers; 2009; 24(1):52-6. PubMed ID: 19404923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do high levels of CA 19-9 in women with mature cystic teratomas of the ovary warrant further evaluation?
    Ugur MG; Ozturk E; Balat O; Dikensoy E; Teke S; Aydin A
    Eur J Gynaecol Oncol; 2012; 33(2):207-10. PubMed ID: 22611965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.
    Cho HY; Kim K; Jeon YT; Kim YB; No JH
    Med Sci Monit; 2013 Mar; 19():230-5. PubMed ID: 23539074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mature Cystic Teratoma of Ovary with Abnormally High Levels of Ca19-9: A Case Report.
    Sampaio J; Sarmento-Gonçalves I; Barros JM; Felix J; Tiago-Silva P
    Rev Bras Ginecol Obstet; 2016 Jul; 38(7):365-7. PubMed ID: 27434195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign teratoma in an 85-year-old woman.
    Takahashi K; Shinno T; Watanabe Y; Kurioka H; Miyazaki K
    Arch Gynecol Obstet; 2000 Apr; 263(4):188-90. PubMed ID: 10834329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic mass associated with raised CA 125 for benign condition: a case report.
    Asher V; Hammond R; Duncan TJ
    World J Surg Oncol; 2010 Apr; 8():28. PubMed ID: 20398372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
    Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
    Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers in mature cystic teratomas of the ovary.
    Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case of mature cystic teratoma of the greater omentum misdiagnosed as ovarian cyst.
    Yoshida A; Murabayashi N; Shiozaki T; Okugawa T; Tabata T
    J Obstet Gynaecol Res; 2005 Oct; 31(5):399-403. PubMed ID: 16176507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of CA19-9 in ovarian mature cystic teratoma.
    Fan JT; Yan HQ; Malla S; Fan YJ; Xu H; Li DH; Liu Y
    Clin Exp Obstet Gynecol; 2016; 43(4):522-525. PubMed ID: 29734540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA19-9 may have clinical significance in mature cystic teratomas of the ovary.
    Dede M; Gungor S; Yenen MC; Alanbay I; Duru NK; Haşimi A
    Int J Gynecol Cancer; 2006; 16(1):189-93. PubMed ID: 16445632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoamputation of an ovarian mature cystic teratoma: a case report and a review of the literature.
    Lee KH; Song MJ; Jung IC; Lee YS; Park EK
    World J Surg Oncol; 2016 Aug; 14(1):217. PubMed ID: 27535361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple neuroectodermal tumors arising in a mature cystic teratoma of the ovary.
    Oláh KS; Needham PG; Jones B
    Gynecol Oncol; 1989 Aug; 34(2):222-5. PubMed ID: 2753429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of mature teratomas containing malignant elements.
    Hirai K; Ishiko O; Itoh F; Nakagawa E; Kanaoka Y; Sumi T; Ogita S
    Oncol Rep; 2000; 7(3):655-7. PubMed ID: 10767385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary malignant melanoma arising from ruptured ovarian mature cystic teratoma with elevated serum CA 19-9: a case report and review of literature.
    Choi WK; Lee DH; Cho DH; Jang KY; Kim KM
    BMC Womens Health; 2019 Nov; 19(1):149. PubMed ID: 31775731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gangliocytic paraganglioma arising from mature cystic teratoma of the ovary.
    Mahdavi A; Silberberg B; Malviya VK; Braunstein AH; Shapiro J
    Gynecol Oncol; 2003 Aug; 90(2):482-5. PubMed ID: 12893225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Grade Astrocytoma within a Mature Cystic Teratoma in an Adolescent Patient.
    Yoder N; Marks A; Hui P; Litkouhi B; Cron J
    J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):325-327. PubMed ID: 29107097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.